Vega Joshua, Bisognano John D
Department of Internal Medicine, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York.
Department of Internal Medicine, Division of Cardiology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York.
Semin Nephrol. 2014 May;34(3):247-56. doi: 10.1016/j.semnephrol.2014.04.002. Epub 2014 Apr 18.
Resistant hypertension is a relevant condition gaining special attention given its clinical and economic impact. Although the true prevalence is unknown, clinical trials and population-based studies have shown that it is a common clinical problem that likely will increase in incidence with an aging and more obese population. A complex interaction of various risk factors including lifestyle, associated conditions, and identifiable secondary causes can lead to uncontrolled hypertension. Important factors including improper blood pressure measuring technique, poor medication adherence, and the white coat phenomenon can lead to pseudoresistance, or a false impression of treatment resistance, which must be excluded. Patients with true resistant hypertension have a greater risk for developing adverse cardiovascular events compared with those with controlled blood pressure, leading to an unfavorable prognosis without adequate treatment. This article reviews the current understanding of the epidemiology of resistant hypertension.
顽固性高血压是一种因其临床和经济影响而受到特别关注的相关病症。尽管其真实患病率尚不清楚,但临床试验和基于人群的研究表明,这是一个常见的临床问题,随着人口老龄化和肥胖程度增加,其发病率可能会上升。包括生活方式、相关病症和可识别的继发原因在内的各种危险因素之间复杂的相互作用可导致高血压控制不佳。重要因素包括血压测量技术不当、药物依从性差和白大衣现象,这些可导致假性顽固性高血压,即对治疗抵抗的错误印象,必须予以排除。与血压得到控制的患者相比,真正的顽固性高血压患者发生不良心血管事件的风险更高,若未得到充分治疗,预后不佳。本文综述了目前对顽固性高血压流行病学的认识。